Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Clin Exp Urol. 2014 Apr 15;2(1):27-44.

Wnt signaling in castration-resistant prostate cancer: implications for therapy.

Author information

  • 1Department of Urology, University of California, Irvine, Orange, CA 92868, USA.
  • 2Department of Pharmaceutical Sciences, University of California, Irvine, Orange, CA 92868, USA.
  • 3Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA ; Department of Othopeadic Surgery, University of California, Irvine, Orange, CA 92868, USA ; Department of Pathology and Laboratory Medicine, University of California, Irvine, Orange, CA 92868, USA.
  • 4Department of Urology, University of California, Irvine, Orange, CA 92868, USA ; Department of Pharmaceutical Sciences, University of California, Irvine, Orange, CA 92868, USA ; Department of Pharmacology, University of California, Irvine, Orange, CA 92868, USA ; Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA.

Abstract

Increasing evidence has indicated that Wnt signaling plays complex roles in castration resistant prostate cancer (CRPC). Although not all data were consistent, β-catenin nuclear localization and its co-localization with androgen receptor (AR) were more frequently observed in CRPC compared to hormone naïve prostate cancer. This direct interaction between AR and β-catenin seemed to elicit a specific expression of a set of target genes in low androgen conditions in CRPC. Paracrine Wnt signaling also was shown to aid resistance to chemotherapy and androgen deprivation therapy. Results from the next generation sequencing studies (i.e. RNA-seq and whole exosome sequcing) of CRPC specimens have identified the Wnt pathway as one of the top signaling pathways with significant genomic alterations in CRPC, whereas, Wnt pathway alterations were virtually absent in hormone naïve primary prostate cancer. Furthermore, Wnt signaling has been suggested to play an important role in cancer stem cell functions in prostate cancer recurrence and resistance to androgen deprivation therapy. Therefore, in this review we have summarized existing knowledge regarding potential roles of Wnt signaling in CRPC and underline Wnt signaling as a potential therapeutic target for CRPC. Further understanding of Wnt signaling in castration resistance may eventually contribute new insights into possible treatment options for this incurable disease.

KEYWORDS:

Wnt signaling; castration-resistant prostate cancer; targeted therapy

PMID:
25143959
[PubMed]
PMCID:
PMC4219296
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk